Article
Ensovibep, a novel trispecific DARPin candidate that protects against SARS-CoV-2 variants
2021-12-20
Abstract excerpt
<title>Abstract</title> <p>SARS-CoV-2 has infected millions of people globally and continues to undergo evolution. Emerging variants can be partially resistant to vaccine induced and therapeutic antibodies, emphasizing the urgent need for accessible, broad-spectrum therapeutics. Here, we report a comprehensive study of ensovibep, the first trispecific clinical DARPin candidate, that can simultaneously engage all...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3e231db4-bdf8-52b8-b7d1-91595bc8a4a0
- DOI
- 10.21203/rs.3.rs-1170399/v1
